Prudent Man Advisors, LLC Novartis Ag Transaction History

Prudent Man Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $46,777 - $53,258	-491 Reduced 17.38%	2,334 $225,000
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $28,142 - $30,969	-305 Reduced 9.74%	2,825 $285,000
Q3 2023 Nov 09, 2023	SELL	$94.73 - $105.13 $10,515 - $11,669	-111 Reduced 3.42%	3,130 $318,000
Q1 2023 May 05, 2023	BUY	$80.03 - $92.81 $560 - $649	7 Added 0.22%	3,241 $298,000
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $244,328 - $299,209	3,234 New	3,234 $293,000
Q2 2022 Aug 05, 2022	SELL	$80.52 - $93.75 $205,889 - $239,718	-2,557 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $43,117 - $47,678	-541 Reduced 17.46%	2,557 $224,000
Q2 2021 Aug 03, 2021	BUY	$85.24 - $94.15 $7,671 - $8,473	90 Added 2.99%	3,098 $283,000
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $4,342 - $5,120	-52 Reduced 1.7%	3,008 $257,000
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $858 - $1,038	-11 Reduced 0.36%	3,060 $289,000
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $5,092 - $5,642	-62 Reduced 1.98%	3,071 $267,000
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $253,553 - $285,416	3,133 New	3,133 $274,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Prudent Man Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prudent Man Advisors, LLC with notifications on news.